Healx, a pioneer in AI-powered drug discovery for rare and neglected conditions, has partnered with SCI Ventures - the world’s first specialist venture fund focused on curing paralysis- to accelerate ...

As Indian IT enters FY26, Indian IT giants have been announcing work on hundreds of AI agents and drug discovery. TCS, Infosys, Wipro, and Tech Mahindra have all been partnering with AI startups for ...

Specno has launched its AI-powered Research and Development acceleration suite, which will help companies to fast-track R&D to speed up and reduce the cost of product development across sectors. “The ...

The company commissioned economic modelling that suggests AI could unlock $115 billion in value by 2030 if Australia gets ...

Scientists at Shaanxi Normal University have developed an AI-powered dual-channel model that predicts miRNA–drug interactions with up to 96% ...

A $40 million London-based fund backed by the Christopher & Dana Reeve Foundation, among others, today unveils its first ...

AI’s perfection cannot capture the imperfections of the human mind -- which touches our souls differently by creating nuanced ...

XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced ...

Given the variability between labs and the unique nature of R&D work, custom, niche AI tools are going to become much more ...

ResearchAndMarkets projects the AI medical diagnostics market to surge to $46.59 billion by 2034, driven by a blistering 33.72% CAGR. Private equity firms believe 2025 could eclipse 2024 as the ...

XtalPi has accrued a number of Big Pharma partners over the years, including Eli Lilly, which struck a $250 million deal in 2023 to use XtalPi’s tech to identify potential drug candidates that Lilly ...